Precision | AI-Designed | Clinical Stage
targeting difficult to treat solid tumors
Rebooting the immune system to deploy a targeted, durable and potent anti-tumor attack
partnership news
immunotherapy meets AI to tackle brain cancer
iOncologi has partnered with SandboxAQ, an Alphabet spinout and leader in AI & quantum technology, to co-develop a next-generation immunotherapy for glioblastoma (GBM)—one of the most lethal and treatment-resistant brain tumors.
The collaboration combines iOncologi’s clinical-stage immunotherapy platforms with SandboxAQ’s AQBioSim™ AI engine to rapidly design, simulate, and optimize precision therapies. This partnership brings together deep tech and translational medicine to tackle GBM—a cancer with a median survival of less than 15 months and limited treatment options.
Together, we aim to bring an AI-built, immune-guided, and patient-adaptable immunotherapy into the clinic within 18 months—redefining the future of solid tumor immunotherapy.
breakthrough platforms
precision lipid-based multilamellar nanocomplex
precision lipid-based multilamellar nanocomplex
precision lipid-based multilamellar nanocomplex
Genetically-engineered precision immunotherapies that rapidly reprogram systemic immunity to elicit a potent and sustained anti-tumor attack
Tumor-targeting biodrones
precision lipid-based multilamellar nanocomplex
precision lipid-based multilamellar nanocomplex
Proprietary nanoparticles that deliver immunotherapy payloads directly to tumor target cells, maximizing efficacy and minimizing toxicity
Cell mediated immune reset
precision lipid-based multilamellar nanocomplex
Cell mediated immune reset
Cell-based immunotherapy that reprograms the tumor landscape, disarming a solid tumor's resistance to immune checkpoint inhibitors
a leading deep tech immunotherapy company
Immuno-Genomics
iOncologi is working with strategic partners to leverage AI Immune Intelligence models to identify breakthrough targets and rapidly deliver bespoke immunotherapies for refractory CNS solid tumors .
Novel manufacturing methods
iOncologi is advancing proprietary manufacturing processes to scale up and rapidly deliver precision immunotherapies
Our Partners
Contact Us
